Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis

Hepato-Gastroenterology

Volumn 50, Issue 53, 2003, Pages 1426-1430

  Tuncer, Ilyas ^a   Topcu, Nazan ^a   Durmus, Ahmet ^a   Turkdogan, M Kursad ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Cefotaxime; Ceftriaxone; Ciprofloxacin; Spontaneous ascites infection

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN;

ADULT; ARTICLE; BACTERIAL PERITONITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DRUG COST; DRUG EFFICACY; FEMALE; HUMAN; INCIDENCE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS BACTERIAL PERITONITIS; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; ANTI-INFECTIVE AGENTS; ASCITIC FLUID; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PERITONITIS; PROSPECTIVE STUDIES;

EID: 0141651611     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Mowat C, Stanley AJ: Spontaneous bacterial peritonitis-diagnosis, treatment and prevention. Aliment Pharmacol Ther 2001; 15:1851-1859.
2. Franca A, Giordano HM, Seva-Pereira T, Soares EC: Five days of ceftriaxone to treat spontaneous bacterial peritonitis in cirrhotic patients. J Gastroenterol 2002; 37:119-122.
3. Ljubicic N, Spajic D, Vrkljan MM, et al: The value of ascitic fluid polymorphonuclear cell count determination during therapy of spontaneous bacterial peritonitis in patients with liver cirrhosis. Hepatogastroenterology 2000; 47:1360-1363.
4. Ricart E, Soriano G, Novella MT, et al: Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J Hepatol 2000; 32:596-602.
5. Terg R, Cobas S, Fassio E, et al: Oral ciprofloxacin after a short course of intravenous ciprofloxacin in treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study. J Hepatol 2000; 33:564-569.
6. Caly WR, Strauss E: A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993; 18:271-272.
7. Inadomi J, Sonnenberg A: Cost analaysis of prophylactic antibiotics in spontaneous bacterial peritonitis. Gastroenterology 1997; 113:1289-1294.
8. Guarner C, Sola R, Soriano G, et al: Risk of a firs community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology 1999; 117:414-419.
9. Runyon BA: Albumin infussion for spontaneous bacterial peritonitis. Lancet 1999; 354:1838-1839.
10. Garsia-Tsao G: Identifying new risk factors for spontaneous bacterial peritonitis: how important is it? Gastroenterology 1999; 117:495-498.
11. Rimola A, Garcia-Tsao G, Navasa M, et al: Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000; 32:142-153.
12. Garcia-Tsao G: Treatment of spontaneous bacterial peritonitis. In: Arroya V, Bosch J, Bruix J (Eds.). Therapy in hepatology. Barcelona: Ars madica, 2001; pp. 59-64.
13. Soares-Weiser K, Paul M, Brezis M, Leibovici L: Evidence based case report. Antibiotic treatment for spontaneous bacterial peritonitis. BMJ 2002; 324:100-102.
14. Gomez-Jimenez J, Ribera E, Gasser I, et al: Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients. Antimicrob Agents Chemoter 1993; 37:1587-1592.
15. Navasa M, Follo A, Llovet JM, et al: Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology 1996; 111:1011-1017.
16. Cornaglia G, Pompei R, Dainelli B, Satta G: In vitro activity of ciprofloxacin against aerobic bacteria isolated in a Southern European Hospital. Antimicrob Agents Chemother 1987; 31:1651-1655.
17. Hsieh WJ, Lin HC, Hwang SJ, et al: The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol 1998; 93:962-966.
18. Ortiz J, Soriano G, Coll P, et al: Early microbiologic diagnosis of spontaneous bacterial peritonitis with Bact/ALERT. J Hepatol 1997; 26:839-844.
19. Runyon BA, Mchutchison JG, Antillon MR, et al: Short course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. Gastroenterology 1991; 100:1737-1742.
20. Correia JP, Conn HO: Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic? Med Clin North Am 1975; 59:963-981.
21. Rimola A, Navasa M, Arroyo V: Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis. Diagn Microbiol Infect Dis 1995; 22:141-145.
22. Fernandez J, Bauer TM, Navasa M, Rodes J: Diagnosis, treatment and prevention of spontaneous bacterial peritonitis. Baillieres Best Pract Res Clin Gastroenterol 2000; 14:975-990.
23. Terg R, Levi D, Lopez P, et al: Analysis of clinical course and prognosis of culture-positive spontaneous bacterial peritonitis. and neutrocytic ascites. Evidence of the same disease. Dig Dis Sci 1992; 37:1499-1504.
24. Smith CR: The advers effects of fluoroquinolones. J Antimicrob Chemother 1987; 20:709-711.
25. Rolachon A, Cordier L, Bacq Y, et al: Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: Results of a prospective controlled trial. Hepatology 1995; 22:1171-1174.
26. Sort P, Gines P, Navasa M, Arroyo V: Current treatment of ascites and spontaneous bacterial peritonitis in Spain: analysis of a survey of gastroenterologists and hepatologists. Gastroenterol Hepatol 1997; 20:437-441.
27. Felisart J, Rimola A, Arroyo V, et al: Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 1985; 5:457-462.
28. Rimola A, Salmeron JM, Clemente G, et al: Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology 1995; 21:674-679.
29. Runyon BA, Akriviadis EA, Sattler FR, Cohen J: Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients treated for bacterial peritonitis. Dig Dis Sci 1991; 12:1782-1786.
30. Toledo C, Salmeron JM, Rimola A, et al: Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993; 17:251-257.
31. Mesquita MA, Balbino EPS, Albuquerque RS, et al: Ceftriaxone in the treatment of spontaneous bacterial peritonitis: ascitic fluid polymorphonuclear count response and short-term prognosis. Hepatogastroenterology 1997; 44:1276-1280.
32. Javid G, Khan BA, Khan BA, et al: Short-course ceftriaxone therapy in spontaneous bacterial peritonitis. Postgrad Med J 1998; 74:592-595.
33. Mercader J, Gomez J, Ruiz J, et al: Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients. Chemotherapy 1989; 35(Suppl 2):23-26.